Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

ETHSX vs. SCHLX: which is better?

Bottom line

ETHSX vs SCHLX: the short answer

ETHSX (Eaton Vance Worldwide Health Sciences Fund) and SCHLX (DWS Health and Wellness Fund) share a meaningful slice of their top holdings — about 70% by weight.

SCHLX is cheaper at 1.06% vs 1.18% — a difference of $12 a year per $10,000 invested.

ETHSX has a front-end sales load of up to 5.25%; the other does not.

Updated Nov 19, 2026

ETHSX vs SCHLX side by side

ETHSXSCHLX
TypeMutual fundMutual fund
Fund familyMorgan StanleyDWS (Xtrackers)
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.18%1.06%
Annual cost per $10k$118$106
10-yr cost on $10k (prospectus)$1,911$1,294
Max front load5.25%0%
12b-1 fee0.25%0%
1-yr return−1.9%—
5-yr return (annualized)+5.3%—
10-yr return (annualized)+6.4%—
Best quarter+14.2%—
Worst quarter−12.1%—
Net assets (fund)$757.9M$231.8M
Number of holdings4265
Portfolio turnover3%2%
Returns as ofDec 31, 2024—

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

16 of ETHSX's top 25 holdings also appear in SCHLX's top 25.

Shared top holdings
HoldingETHSXSCHLX
Eli Lilly & Co12.47%13.85%
AbbVie Inc6.46%4.90%
Johnson & Johnson6.45%6.19%
AstraZeneca PLC6.24%3.80%
UnitedHealth Group Inc5.49%5.73%
Roche Holding AG5.44%1.24%
Merck & Co Inc5.08%4.85%
Bristol-Myers Squibb Co4.25%1.50%
Vertex Pharmaceuticals Inc3.38%2.45%
Gilead Sciences Inc3.34%2.78%
Thermo Fisher Scientific Inc2.79%3.46%
Intuitive Surgical Inc2.72%2.69%
Stryker Corp2.21%2.61%
Boston Scientific Corp2.18%2.10%
Medtronic PLC1.80%1.54%

Source: SEC Form N-PORT

ETHSX top 10

  1. Eli Lilly & Co — 12.47%
  2. AbbVie Inc — 6.46%
  3. Johnson & Johnson — 6.45%
  4. AstraZeneca PLC — 6.24%
  5. UnitedHealth Group Inc — 5.49%
  6. Roche Holding AG — 5.44%
  7. Merck & Co Inc — 5.08%
  8. Bristol-Myers Squibb Co — 4.25%
  9. Vertex Pharmaceuticals Inc — 3.38%
  10. Gilead Sciences Inc — 3.34%

SCHLX top 10

  1. Eli Lilly & Co — 13.85%
  2. Johnson & Johnson — 6.19%
  3. UnitedHealth Group Inc — 5.73%
  4. AbbVie Inc — 4.90%
  5. Merck & Co Inc — 4.85%
  6. AstraZeneca PLC — 3.80%
  7. Thermo Fisher Scientific Inc — 3.46%
  8. Novartis AG — 2.90%
  9. Amgen Inc — 2.88%
  10. Gilead Sciences Inc — 2.78%

FAQ

What is the difference between ETHSX and SCHLX?
ETHSX (Eaton Vance Worldwide Health Sciences Fund) and SCHLX (DWS Health and Wellness Fund) share a meaningful slice of their top holdings — about 70% by weight. SCHLX is cheaper at 1.06% vs 1.18% — a difference of $12 a year per $10,000 invested.
Which is cheaper, ETHSX or SCHLX?
SCHLX has the lower expense ratio (1.06%).
Should I own both ETHSX and SCHLX?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.